banner
Home / News / Stanford Medicine researchers take part in HuBMAP, showing what healthy human tissue looks like
News

Stanford Medicine researchers take part in HuBMAP, showing what healthy human tissue looks like

Nov 23, 2023Nov 23, 2023

Stanford Medicine scientists describe details of the human intestine and placental tissue as part of the National Institute of Health’s Human Biomolecular Atlas Program.

July 19, 2023 - By Hanae Armitage

'In research, we have a habit of studying things that are abnormal without really understanding what normal looks like,' said Stanford Medicine's Michael Angelo.Snyder lab

More often than not, studies of human biology are conducted when the body is under duress from infection or disease. Now, as part of a larger effort to delineate what “healthy” looks like, two Stanford Medicine teams have unfurled detailed molecular maps of healthy human intestinal and placental tissues. The maps, which capture cell types, cell quantity and other cellular nuances, are just two of a collection of maps that will establish a cellular baseline for the majority of the human body, including where cells in certain tissues congregate, how tissues develop during pregnancy and how cell-to-cell interactions drive human biology.

The studies, which published in Nature on July 19, are part of a larger effort spearheaded by the Human Biomolecular Atlas Program — called HuBMAP — funded by the National Institutes of Health. It aims to fill gaps in our knowledge of how the human body works when it’s in tip-top shape. Dozens of teams from the United States and Europe contribute to the HuBMAP consortium.

“In research, we have a habit of studying things that are abnormal without really understanding what normal looks like,” said Michael Angelo, MD, PhD, an assistant professor of pathology who is also the co-chair of the HuBMAP steering committee. “That’s created a big gap in our knowledge. HuBMAP is the only effort that is systematically focusing on the spatial architecture of these tissues.”

Michael Angelo and Mike Snyder

By combining cellular imaging techniques, machine learning and other methods of molecular analyses, the teams are creating a comprehensive resource for researchers to better understand all human tissue. The data collected during the project, including imaging data and annotations, will be publicly available through HuBMAP. The goal is to enable researchers to study tissue-specific characteristics, understand disease mechanisms, and develop automated annotation tools that identify and characterize cells.

In contributing to mapping the human body overall, Michael Snyder, PhD, the Stanford W. Ascherman Professor of Genetics and former co-chair of the HuBMAP steering committee, and his team focused on the intestine, revealing key characteristics of this type of tissue:

Angelo’s team focused on the maternal-fetal tissue remodeling process, in which cells from the fetus embed into the uterine wall. Their study detailed several key pieces of developmental biology during pregnancy:

Snyder and Angleo hope that establishing detailed baselines, in coordination with dozens of other research teams creating cellular maps within HuBMAP, will help scientists further understand what happens when healthy bodies become diseased.

“These are really some of the first highly detailed spatial maps of the human body, allowing us to see not just what cells are there, but how they’re organized,” Snyder said. “It’s hard to understand disease if you don’t know what the healthy states look like. These maps will allow us to start comparing across different organs and analyzing what goes wrong during disease.”

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Tuberculosis lesions in the lungs have high levels of proteins that suppress the immune system. Cancer drugs that target these proteins could be used to fight the bacterial infection.

How the environment and health interact